Back to search
FDAFDA · Food and drugs·Recall number Z-2319-2017

Nexstim eXima NBS System Software version 2.2 or higher. The Nexstim Navigated Brain Stimulation System (NBS System) is indicated for noninvasive mapping of the primary motor cortex of the brain to its cortical gyrus. The NBS System provides information that may be used in the assessment of the primary motor cortex for pre-procedural planning. The NBS System is not intended to be used during a surgical procedure. The NBS System is intended to be used by trained clinical professionals.

Published June 14, 2017 · Recall initiated: March 14, 2017

Summary

FDA records medical device Class II recall Z-2319-2017, published June 14, 2017 and initiated March 14, 2017. Recalling firm: Nexstim PLC; Status: Ongoing; Reported quantity: 11 units.; Lot: Serial numbers: NBS101, NBS106, NBS140, NBS141, NBS145, NBS148, NBS155, NBS159, NBS163, NBS164, NBS166. NBS158 has been scrapped. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Software defect: the NBS software may accidentally generate duplicate copies of one or several files.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Nexstim PLC
Distributor
Worldwide Distribution - US to GA only, Foreign: Europe
Lot
Serial numbers: NBS101, NBS106, NBS140, NBS141, NBS145, NBS148, NBS155, NBS159, NBS163, NBS164, NBS166. NBS158 has been scrapped.
Risk classification
Class II
Area (FDA)
device
Country
Finland

Related recalls

Questions about this recall

Was Nexstim eXima NBS System Software version 2.2 or higher. The Nexstim Navigated Brain Stimulation System (NBS System) is indicated for noninvasive mapping of the primary motor cortex of the brain to its cortical gyrus. The NBS System provides information that may be used in the assessment of the primary motor cortex for pre-procedural planning. The NBS System is not intended to be used during a surgical procedure. The NBS System is intended to be used by trained clinical professionals. recalled?

Yes. FDA published recall Z-2319-2017 on June 14, 2017. Reported hazard: Software defect: the NBS software may accidentally generate duplicate copies of one or several files.

What should I do if I have this product?

Voluntary: Firm initiated · Letter